Hiroyoshi Horikoshi

5.6k citations
57 papers · 4.6k indexed · 2 hit papers · h-index 24
Topics
Metabolism, Diabetes, and Cancer (12 papers)Adipose Tissue and Metabolism (12 papers)Pancreatic function and diabetes (9 papers)

In The Last Decade

Hiroyoshi Horikoshi

55 papers receiving 4.4k citations

Hit Papers

Troglitazone increases the number of small adipocytes wit...199420262004201519981994250500750

Peers

Hiroyoshi Horikoshi
Comparison fields: 5 of 112
  • Molecular Biology 2.7k
  • Physiology 1.4k
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Epidemiology 908
  • Surgery 827
Replace Ripudaman S. Hundal with:
Ripudaman S. Hundal United States
Todd Leff United States
John Ventre United States
Cristina M. Rondinone United States
Jerry R. Colca United States
Kathleen K. Brown United States
I. George Fantus Canada
I. George Fantus Canada
Judy Fenyk‐Melody United States
Visvanathan Chandramouli United States
Hiroyoshi Horikoshi relative to Ripudaman S. Hundal United States Ripudaman S. Hundal's profile →
Citations per field
00.5×1.5×
Ripudaman S. Hundal · 1×
Citations per year

Countries citing papers authored by Hiroyoshi Horikoshi

Since Specialization
Citations

This map shows the geographic impact of Hiroyoshi Horikoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Horikoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Horikoshi more than expected).

Fields of papers citing papers by Hiroyoshi Horikoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Horikoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Horikoshi. The network helps show where Hiroyoshi Horikoshi may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Horikoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Horikoshi. A scholar is included among the top collaborators of Hiroyoshi Horikoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Horikoshi. Hiroyoshi Horikoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 43
3 344
4 55
5 15
6 7
7 3
8 10
9 25
10 52
11
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.breakdown →
875
12 12
13 26
14 22
15 88
16 59
17 18
18 101
19 23
20 190

About Hiroyoshi Horikoshi

Hiroyoshi Horikoshi is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Physiology, having authored 57 papers that have together received 4.6k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (12 papers), Adipose Tissue and Metabolism (12 papers) and Pancreatic function and diabetes (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Physiology (1.4k citations) and Biochemistry (285 citations). Hiroyoshi Horikoshi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Toshihiko Fujiwara, Shinji Yoshioka, Takuya Fujiwara, Takao Yoshioka, Akira Okuno, Takashi Kadowaki, Hiroyuki Tamemoto, Izumi Ushiyama, Y. Akanuma and Yusaku Mori. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026